Friday 29 July 2016

Detailed Report on Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2016

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Chemotherapy Induced Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chemotherapy Induced Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Companies Mentioned
CK Life Sciences Int'l., (Holdings) Inc. Amgen Inc. Alliance Healthcare S.A. Pfizer Inc. Neurotune AG NEMA Research Inc. Lannett Company, Inc. Helsinn Holding S.A.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

Market Review on Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016

Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Hormone Sensitive Breast Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone Sensitive Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
To view the table of contents and know more details please visit Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Companies Mentioned
Pfizer Inc. AstraZeneca Plc GlaxoSmithKline Plc Dr. Reddy's Laboratories Limited Mylan N.V. Genesis Capital s.r.o. F. Hoffmann-La Roche Ltd. Bluefish Pharmaceuticals AB AXIS Clinicals Limited Allied Research International Inc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

Recent Report on Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Hormone-Sensitive Prostate Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone-Sensitive Prostate Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
To view the table of contents and know more details please visit Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Companies Mentioned
Johnson & Johnson Ferring International Center S.A. Novartis AG Sanofi Pfizer Inc. Medivation, Inc. Astellas Pharma Inc. Aeterna Zentaris Inc. CMX Research Inc. Besins Healthcare S.A.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

New Report sheds light on the Meningioma Global Clinical Trials Review, H1, 2016

Meningioma Global Clinical Trials Review, H1, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Meningioma clinical trials scenario. This report provides top line data relating to the clinical trials on Meningioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
To access full report with TOC, please visit Meningioma Global Clinical Trials Review, H1, 2016
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Companies Mentioned
Novartis AG F. Hoffmann-La Roche Ltd. Pfizer Inc. e-Therapeutics Plc C. H. Boehringer Sohn AG & Co. KG Burzynski Research Institute, Inc. AstraZeneca Plc Arno Therapeutics, Inc. Advanced Accelerator Applications S.A. AbbVie Inc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

Recent Report on B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 is a new market research publication announced by Reportstack. This report provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Companies Mentioned
F. Hoffmann-La Roche Ltd. Celgene Corporation Johnson & Johnson Novartis AG AbbVie Inc. Takeda Pharmaceutical Company Limited Amgen Inc. GlaxoSmithKline Plc Bayer AG Pfizer Inc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

Detailed Report on Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2016

Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Hormone Refractory Breast Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone Refractory Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Companies Mentioned
F. Hoffmann-La Roche Ltd. Novartis AG Neovii Biotech GmbH Neopharm Ltd. NeoCorp GmbH Jina Pharmaceuticals Inc. C. H. Boehringer Sohn AG & Co. KG Bluefish Pharmaceuticals AB Bioenvision Limited AstraZeneca Plc
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

Market Research Outlook on Penile Cancer Global Clinical Trials Review, H1, 2016

Penile Cancer Global Clinical Trials Review, H1, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Penile Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Penile Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Companies Mentioned
Pfizer Inc. Oryx GmbH & Co. KG Merck & Co., Inc. Bristol-Myers Squibb Company Advaxis, Inc. Laboratoires Pierre Fabre SA Kite Pharma, Inc. ISA Pharmaceuticals B.V. GlaxoSmithKline Plc F. Hoffmann-La Roche Ltd.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

New Report Explores on Neuroblastoma Global Clinical Trials Review, H1, 2016

Neuroblastoma Global Clinical Trials Review, H1, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Neuroblastoma clinical trials scenario. This report provides top line data relating to the clinical trials on Neuroblastoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
To view the table of contents and know more details please visit Neuroblastoma Global Clinical Trials Review, H1, 2016
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Companies Mentioned
Progenics Pharmaceuticals, Inc. APEIRON Biologics AG F. Hoffmann-La Roche Ltd. United Therapeutics Corporation Children's Healthcare of Atlanta Inc. GlaxoSmithKline Plc Novartis AG Children’s Cancer and Leukaemia Group Biotec Pharmacon ASA AstraZeneca Plc
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###